中华传染病杂志
中華傳染病雜誌
중화전염병잡지
CHINESE JOURNAL OF INFECTIOUS DISEASES
2009年
4期
212-216
,共5页
杜维波%潘小平%陈佳佳%章益民%陈瑜%李兰娟
杜維波%潘小平%陳佳佳%章益民%陳瑜%李蘭娟
두유파%반소평%진가가%장익민%진유%리란연
肝功能衰竭,急性%半乳糖%肝,人工%猪%疾病模型,动物
肝功能衰竭,急性%半乳糖%肝,人工%豬%疾病模型,動物
간공능쇠갈,급성%반유당%간,인공%저%질병모형,동물
Liver failure,acute%Galactos%Liver,artificial%Swine%Disease model,animal
目的 建立和改进D-氨基半乳糖(D-gal)诱导的猪急性肝功能衰竭模型,探讨其应用于人工肝临床前评价的可行性.方法 19只杜洛克种猪分成4组,其中15只(每组5只)在无麻醉条件下通过颈静脉置管分别注射1.0、1.25及1.5 g/kg的D-gal,其余4只注射等量的5%葡萄糖液作为对照组.记录动物临床表现和存活时间,动态检测血氨、PT、肝肾功能、血糖、L-乳酸等指标和肝组织学变化.采用t检验及F检验比较上述指标的组间差异,采用Kaplan-Meier生存分析及LogRank检验比较动物存活时间.结果 注射D-gal 12 h后,所有动物出现明显的肝损伤表现,表现为血氨、AST、TBil及L-乳酸水平进行性升高,血糖水平显著下降,PT逐渐延长,与对照组比较,差异有统计学意义(F=32.33,F=27.817,F=50.097,F=88.382,F=8.211,F=21.227;均P<0.01),尤以注射1.5 g/kg D-gal组的变化为著.接受1.0 g/kg D-gal的动物除2只存活超过168 h外,其余3只于68~84 h内死亡,而接受1.25 g/kg和1.5 g/kg D-gal的动物分别于33~89 h和23~47 h内死亡,死前均出现昏迷,病理学检查提示肝组织大片坏死伴出血.结论 在无麻醉条件下D-gal诱导的杜洛克种猪急性肝功能衰竭模型均具有潜在的可逆性和良好的重复性,且具有合适的治疗时间窗口,适宜于人工肝疗效和安全性评价研究.
目的 建立和改進D-氨基半乳糖(D-gal)誘導的豬急性肝功能衰竭模型,探討其應用于人工肝臨床前評價的可行性.方法 19隻杜洛剋種豬分成4組,其中15隻(每組5隻)在無痳醉條件下通過頸靜脈置管分彆註射1.0、1.25及1.5 g/kg的D-gal,其餘4隻註射等量的5%葡萄糖液作為對照組.記錄動物臨床錶現和存活時間,動態檢測血氨、PT、肝腎功能、血糖、L-乳痠等指標和肝組織學變化.採用t檢驗及F檢驗比較上述指標的組間差異,採用Kaplan-Meier生存分析及LogRank檢驗比較動物存活時間.結果 註射D-gal 12 h後,所有動物齣現明顯的肝損傷錶現,錶現為血氨、AST、TBil及L-乳痠水平進行性升高,血糖水平顯著下降,PT逐漸延長,與對照組比較,差異有統計學意義(F=32.33,F=27.817,F=50.097,F=88.382,F=8.211,F=21.227;均P<0.01),尤以註射1.5 g/kg D-gal組的變化為著.接受1.0 g/kg D-gal的動物除2隻存活超過168 h外,其餘3隻于68~84 h內死亡,而接受1.25 g/kg和1.5 g/kg D-gal的動物分彆于33~89 h和23~47 h內死亡,死前均齣現昏迷,病理學檢查提示肝組織大片壞死伴齣血.結論 在無痳醉條件下D-gal誘導的杜洛剋種豬急性肝功能衰竭模型均具有潛在的可逆性和良好的重複性,且具有閤適的治療時間窗口,適宜于人工肝療效和安全性評價研究.
목적 건립화개진D-안기반유당(D-gal)유도적저급성간공능쇠갈모형,탐토기응용우인공간림상전평개적가행성.방법 19지두락극충저분성4조,기중15지(매조5지)재무마취조건하통과경정맥치관분별주사1.0、1.25급1.5 g/kg적D-gal,기여4지주사등량적5%포도당액작위대조조.기록동물림상표현화존활시간,동태검측혈안、PT、간신공능、혈당、L-유산등지표화간조직학변화.채용t검험급F검험비교상술지표적조간차이,채용Kaplan-Meier생존분석급LogRank검험비교동물존활시간.결과 주사D-gal 12 h후,소유동물출현명현적간손상표현,표현위혈안、AST、TBil급L-유산수평진행성승고,혈당수평현저하강,PT축점연장,여대조조비교,차이유통계학의의(F=32.33,F=27.817,F=50.097,F=88.382,F=8.211,F=21.227;균P<0.01),우이주사1.5 g/kg D-gal조적변화위저.접수1.0 g/kg D-gal적동물제2지존활초과168 h외,기여3지우68~84 h내사망,이접수1.25 g/kg화1.5 g/kg D-gal적동물분별우33~89 h화23~47 h내사망,사전균출현혼미,병이학검사제시간조직대편배사반출혈.결론 재무마취조건하D-gal유도적두락극충저급성간공능쇠갈모형균구유잠재적가역성화량호적중복성,차구유합괄적치료시간창구,괄의우인공간료효화안전성평개연구.
Objective To establish and improve the acute hepatic failure model in pigs induced with D-galactosamine (D-gal),and explore the feasibility of evaluating preclinical artificial liver devices.Methods Nineteen Duroc breeding pigs were divided into 4 groups.Fifteen unanesthetic Duroc breeding pigs out of 19 (5 of each group) received intravenously administration of D-gal at a dose of 1.0,1.25 and 1.5 g/kg body weight,respectively.The remaining 4 pigs which received the same volume of 5% dextrose in water served as controls. Clinical data and survival time of pigs were recorded.Blood samples were collected for dynamic testing of plasma ammonia,prothrombin time,liver and renal functions,blood glucose and L-lactate;liver tissues were sampled for pathological examination.The differences between groups were compared using t test and F test.The survival time of pigs was compared by Kaplan-Meier survival analysis and Log Rank test.Results Twelve hours after administration of D-gal,all pigs presented as acute hepatic failure characterized by progressive increases of levels of plasma ammonia,aspartate aminotransferase (AST),total bilirubin (TBil) and L-lactate,the level of blood glucose marked decreased and prothrombin time prolonged (F= 32.33,F=27.817,F=50.097,F=88.382,F=8.211,F=21.227;all P<0.01);especially in the pigs which received D-gal at a dose of 1.5 g/kg.Except 2 pigs survived for 168 h,the other 3 pigs which received D-gal at a dose of 1.0 g/kg died within 68-84 h,while all pigs which received D-gal at a dose of 1.25 and 1.5 g/kg died within 33-89 h and 23-47 h,respectively.All pigs presented coma before death and liver histopathological examination indicated massive hepatic necrosis with severe hemorrhage.Conclusions D-gal induced acute hepatic failure model in unanesthetic Duroc breeding pig appears potential reversibility and high reproducibility,which has proper therapeutic window.Thus,this model could be applied to evaluate the therapeutic effects and safety of artificial liver devices.